Targeted proteomics dataset (PRM) investigating four potential biomarker candidates of high-grade serous ovarian carcinoma (FGL2, LGALS3BP, LTBP1, TIMP1) and the established biomarker CA125 in 212 serum samples taken from 34 HGSC patients during disease progression.
[doi:10.25345/C5NG4H296]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: targeted proteomics ; parallel reaction monitoring ; PRM ; high-grade serous ovarian carcinoma ; ovarian cancer ; serum biomarker ; surveillance biomarker ; biomarker validation
|
Principal Investigators: (in alphabetical order) |
Dr. Thomas Kislinger, Princess Margaret Cancer Centre, Canada |
| Submitting User: | TKislinger |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|